Magnetic microstructures for magnetic resonance imaging
US-10350312-B2 · Jul 16, 2019 · US
US11324840B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11324840-B2 |
| Application number | US-201916291731-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 4, 2019 |
| Priority date | Apr 3, 2009 |
| Publication date | May 10, 2022 |
| Grant date | May 10, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to a magnetic resonance structure with a cavity or a reserved space that provides contrast and the additional ability to frequency-shift the spectral signature of the NMR-susceptible nuclei such as water protons by a discrete and controllable characteristic frequency shift that is unique to each MRS design. The invention also relates to nearly uniform solid magnetic resonance T2* contrast agents that have a significantly higher magnetic moment compared to similarly-sized existing MRI contrast agents.
Opening claim text (preview).
The invention claimed is: 1. A magnetic resonance contrast agent comprising a plurality of solid disks of uniform size and magnetic moment, wherein each disk consists of a single magnetic material and a coating made of a non-magnetic material, and wherein each disk has a diameter of about 0.1 μm to about 10 μm and a thickness of 0.5 μm to 2 μm. 2. The magnetic resonance contrast agent of claim 1 , wherein each disk has a magnetic moment from about 10 −14 A·m 2 to about 10 −11 A·m 2 . 3. The magnetic resonance contrast agent of claim 1 , wherein each disk varies in size by less than about 5% of the average size of the plurality of disks. 4. The magnetic resonance contrast agent of claim 3 , wherein each disk varies in magnetic moment by less than about 5% of the average magnetic moment of the plurality of disks. 5. The magnetic resonance contrast agent of claim 1 , wherein the magnetic material is iron. 6. The magnetic resonance contrast agent of claim 1 , wherein the non-magnetic material is gold or titanium. 7. The magnetic resonance contrast agent of claim 6 , wherein the non-magnetic material is gold. 8. The magnetic resonance contrast agent of claim 1 , wherein each disk has a diameter of about 1 μm to about 2 μm. 9. The magnetic resonance contrast agent of claim 8 , wherein the magnetic material is iron. 10. The magnetic resonance contrast agent of claim 9 , wherein the non-magnetic material is gold. 11. A magnetic resonance contrast agent comprising a plurality of solid disks of uniform size and magnetic moment, wherein the disks consist of iron and a coating made of titanium, wherein each disk has a diameter of about 0.1 μm to about 10 μm and a thickness of about 0.1 μm to about 10 μm. 12. The magnetic resonance contrast agent of claim 11 , wherein each disk has a diameter of about 1 μm to about 2 μm and a thickness of about 0.5 μm to about 2 μm. 13. A magnetic resonance contrast agent comprising a plurality of solid disks of uniform size and magnetic moment, wherein each disk consists of a single magnetic material and a coating made of a non-magnetic material, wherein each disk has a diameter of about 1 μm to about 2 μm and a thickness of about 0.5 μm to about 2 μm, wherein the magnetic material is iron, and wherein the non-magnetic material is titanium.
involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging · CPC title
Means for the use of in vitro contrast agents (G01R33/282 takes precedence; involving use of a contrast agent in MR imaging G01R33/5601; in vivo contrast agents A61K49/0002) · CPC title
involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent · CPC title
Angiography, e.g. contrast-enhanced angiography [CE-MRA] or time-of-flight angiography [TOF-MRA] · CPC title
characterised by a special physical form, e.g. emulsions, microcapsules, liposomes · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.